Flexion CEO: ‘Absolutely thinking’ about exploring additional uses for new non-opioid drug
October 09, 2017 at 16:19 PM EDT
When asked if Flexion would look to other applications for its new non-opioid drug, CEO Mike Clayman said, "We're absolutely thinking about it."
